O'Keeffe Charles B 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
O'Keeffe Charles B
Director
Transactions
- Exercise/Conversion
Options to purchase common stock
2024-01-02−60,000→ 232,931 totalExercise: $1.13Exp: 2024-01-03→ Common Stock (60,000 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2024-01-02$1.13/sh+60,000$67,800→ 681,724 total
Footnotes (1)
- [F1]Options vested in three annual tranches beginning on January 3, 2018.